NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Llusern Scientific

Llusern Scientific

Private
CardiffHealthcare & Life Scienceshttps://llusern.co.uk/

Last Round

Early Funding

Nov 20, 2025

Total Funding Raised

$225,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Llusern Scientific is a medical technology company that manufactures a molecular diagnostic platform and test panels for point-of-care detection of urinary tract infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care testingmolecular diagnosticsPOCTisothermal amplificationLAMPurinary tract infection testingUTI diagnosticantimicrobial stewardshiprapid diagnosticsmedical device manufacturerveterinary diagnosticsbedside testingdiagnostic analyzerclinical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Llusern Scientific Comps

Public and private peers based on sector, stage, and business model.

Llusern Scientific comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Llusern Scientific Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 20, 2025
SeedOct 10, 2024
GrantSep 1, 2024
AngelMay 21, 2024

Key People

Founding team and executive leadership

Mark Preston

Chief Technology Officer

Executive Team

Maddy Kennedy

CFO

Executive Team

Llusern Scientific Investors

Notable investors and investment history

Llusern Scientific investors
InvestorRounds
Angels Invest WalesEarly Funding
NestaGrant
SFC CapitalSeed
Welsh GovernmentGrant
Development Bank of WalesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors grew 78% MoM, reaching 1.6K.

  • Jan 6, 2026

    Developing Lodestar DX, a molecular diagnostic solution for UTI bacteria.

Llusern Scientific Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Llusern Scientific Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Llusern Scientific's valuation, stock price, and market status.

Firmographic Details

HeadquartersCardiff
Employee Range10
Year Founded2020
Last FundingNov 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.